BioSpace News Archive

Drug Development

Ligand Completes Enrollment of Phase 1 Clinical Trial of Captisol-enabled Iohexol

Also reports recent results from clinician survey on radiocontrast agent selection and use

May 2, 2019
·
8 min read
Pharm Country

Titia de Lange, Ph.D., Director, Anderson Center For Cancer Research, The Rockefeller University, Will Be Keynote Speaker For Gilda’s Club NYC 12th Annual Celebrating Women Benefit Luncheon, May 8th

Gilda’s Club New York City (GCNYC) announced the Keynote Speaker for its 12th Annual Celebrating Women luncheon is Titia de Lange, Ph.D., Head of the Laboratory of Cell Biology and Genetics, and Director of the Anderson Center for Cancer Research at The Rockefeller University.

May 2, 2019
·
2 min read
Drug Development

AKL Research & Development and Nordic Bioscience Collaborate to Take Novel Osteoarthritis Medicine to Phase II

AKL Research & Development (AKLRD) and Nordic Bioscience Clinical Development, today announce a risk-share agreement to assess the efficacy of a novel, oral medicine, APPA, in a phase II trial of Osteoarthritis (OA).

May 2, 2019
·
4 min read
Policy

ZAP Surgical Systems Responds to Elekta Lawsuit

On Friday, April 26, 2019, Elekta Ltd. and its US operating company Elekta, Inc. (“Elekta”) filed a lawsuit against ZAP® Surgical Systems in the United States District Court for the Northern District of California.

May 2, 2019
·
1 min read
Pharm Country

National Kidney Foundation Honors Otsuka Pharmaceutical Company, Ltd. with 2019 Spring Clinical Meetings Corporate Innovator Award

Otsuka Pharmaceutical Company, Ltd. has been selected to receive the 2019 Corporate Innovator Award from the National Kidney Foundation (NKF) at the 2019 Spring Clinical Meetings in Boston.

May 2, 2019
·
3 min read
Pharm Country

Removal of Gene Completely Prevents Development of Aggressive Pancreatic Cancer in Mice

The action of a gene called ATDC is required for the development of pancreatic cancer, a new study finds.

May 2, 2019
·
4 min read
Job Trends

CDISC, C-Path Release Therapeutic Area Standard to Drive Research Forward for Clostridium Difficile Associated Diarrhea

CDISC and The Critical Path Institute (C-Path) are pleased to announce the release of a global Therapeutic Area Standard, which describes how to use CDISC standards to represent data in research studies pertaining to Clostridium difficile associated diarrhea (CDAD).

May 2, 2019
·
4 min read
Improving Clinical Trials Efficiency With the Help of Real World Evidence Engagement | A Case Study by Quantzig

A global data analytics and advisory firm, Quantzig, that delivers actionable analytics solutions to resolve complex business problems has announced the completion of their latest real world evidence engagement for a healthcare service provider.

May 2, 2019
·
2 min read
BioMidwest

Awareness of Fatty Liver Disease Remains Low Among Most At-Risk Patients

The results of a new survey released last week at the 3rd Annual NASH (nonalcoholic steatohepatitis) Summit in Boston show that even among patients most at-risk for the fatty liver disease, awareness of the condition remains low.

May 2, 2019
·
2 min read
Business

The Center for Health Affairs Announces New President and CEO

The Center for Health Affairs’ Board of Directors has named Brian Lane as its new president and CEO, effective May 15.

May 2, 2019
·
2 min read